Immunogenicity 15699

summary
Sample ID
L011
Response
Positive
Tumor Type
NSC Lung cancer
Gene Symbol
MTFR2
Transcript ID
None
HLA INFO
B*35:01
TCR INFO

No TCR info found!

T cell Tumor cell B*35:01
sequence
Full length protein sequence (342 aa)
MLPLE
1
PCRRP
6
NFELI
11
PLLNS
16
VDSDN
21
CGSMV
26
PSFAD
31
ILYVA
36
NDEEA
41
SYLRF
46
RNSIW
51
KNEEE
56
KVEIF
61
HPLRL
66
VRDPL
71
SPAVR
76
QKETV
81
KNDLP
86
VNEAA
91
IRKIA
96
ALENE
101
LTFLR
106
SQIAA
111
IVEMQ
116
ELKNS
121
TNSSS
126
FGLSD
131
ERISL
136
GQLSS
141
SRAAH
146
LSVDP
151
DQLPG
156
SVLSP
161
PPPPP
166
LPPQF
171
SSLQP
176
PCFPP
181
VQPGS
186
NNICD
191
SDNPA
196
TEMSK
201
QNPAA
206
NKTNY
211
SHHSK
216
SQRNK
221
DIPNM
226
LDVLK
231
DMNKV
236
KLRAI
241
ERSPG
246
GRPIH
251
KRKRQ
256
NSHWD
261
PVSLI
266
SHALK
271
QKFAF
276
QEDDS
281
FEKEN
286
RSWES
291
SPFSS
296
PETSR
301
FGHHI
306
SQSEG
311
QRTKE
316
EMVNT
321
KAVDQ
326
GISNT
331
SLLNS
336
RI
341
Mutation Information
DNA mutation:
None
Peptide Range:
278 ~ 286
Mut AA position:
None (None in Wild Type peptide)
Alignment
Wild Type:
"FAFQEDDSF
|||||.|||
Mutant:
FAFQEYDSF"
reference
clinic trial
Checkpoint Blockade

pembrolizumab

ACT

N

Vaccination

N

Curative Effect

clinical benefit

experiment
minimal_peptide

Y

Antigen Type

multimer

T-cell Source

PBMCs

APC Type

None

Assay

None